Abiopharma

🔍 Papadopoulos Didier (Executive)

Company: Joby Aviation, Inc. (JOBY)

Report Date: 2026-06-14

Detailed Transactions and Holdings:

• Acquired 11,641 shares of Common Stock (Direct)
  Date: 2026-06-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 156,429.00 | transaction_form_type: 4
• Sold 5,999 shares of Common Stock at $9.83 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 150,430.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,975 shares of Common Stock at $9.42 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 148,455.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 11,641 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-06-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,566.00 | transaction_form_type: 4 | Footnotes: F4, F4

Footnotes:

• F1: Represents the aggregate number of shares sold by the Reporting Person to cover taxes due upon the release and settlement of the RSUs, as required by the terms of the RSU award.
• F2: Sale made pursuant to the Reporting Person's approved 10b5-1 trading plan adopted on September 2, 2025.
• F3: This transaction was executed in multiple trades at prices ranging from $9.24 to $9.65. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: Represents an award of restricted stock units ("RSUs") that vests with respect to 16.66% of the RSUs on June 14, 2022 and as to the remaining 83.34% in 20 quarterly installments thereafter, subject to the reporting person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.